Shanghai, July 12, 2023 – DNE Group (“DNE”), a leading new economy infrastructure investor, developer and operator in China, announced today that it has established a life sciences park fund (“Fund”) with a number of well-renowned domestic insurance companies to invest in a high-quality life sciences R&D park located in the key economic hub in Shanghai China, with a total investment of over RMB3.5 billion (US$485 million). The investment has been closed following the fund inception in the first quarter of 2023.
As one of the first and largest life sciences infrastructure developer-operators in China, DNE is deeply rooted in the sector. With nearly a decade of successful track record in the life sciences space, it currently operates and manages life sciences parks of over 700,000 square meters in Shanghai and Yangtze River Delta region, and has over 1.5 million square meters secured pipeline projects nation-wide, providing a full range of facilities including high-spec R&D spaces and GMP manufacturing workshops. The project invested by the Fund is located in a core industry cluster in Shanghai Pudong area and provides high-quality R&D facilities to leading domestic and foreign life sciences enterprises. Being the fund and project manager, DNE will also leverage its integrated local team, providing supporting services to the customers as well as full range of asset management services.
“We are pleased to partner with leading insurance investors in China for this opportunity. Due to the scarcity of supply, the growth potential of life sciences industry, as well as the high tenant stickiness, high-spec life sciences parks located in key economic hubs are greatly favored by insurance companies for their stable occupancy and rental income potential, which translate to favorable investment returns,” said Sun Dongping, Chairman and CEO of DNE.
“Domestic insurance investors have closely followed the national development strategies, and have been deeply engaged in new economy infrastructure investments in China in recent years. With strong financial strength and deep understanding of the market, they have actively promoted the development of the sector. This partnership also demonstrated investors’ recognition of DNE’s investment capabilities and track record. In the future, we will continue to invest in the life sciences park sector in China and continue to build the high quality development and operation platform specialized in this area,” he added.
DNE is a leading new economy infrastructure investor, developer and operator in China with over $16 billion in AUM and GFA over 14 million square meters across multiple verticals, including logistics and cold chains, life sciences and modern manufacturing parks, urban redevelopment, and data centers. DNE also runs DNE Capital, a private equity investment platform focusing on new economy industry investment. DNE provides a full range of integrated infrastructure solutions to new economy clients, meeting their needs in R&D, manufacturing, warehousing and corporate headquarters. With a seasoned management team, DNE provides comprehensive capabilities spanning from acquisition, development and construction to asset and fund management. DNE aspires to deliver sustainable long-term value to its new economy clients, capital partners and stakeholders.
For more details about DNE, please visit www.dnegroup.com.